Page 125 - 南京医科大学自然版
P. 125
第44卷第7期 杨 澜,吉宁飞,黄 茂. 肺肉瘤样癌免疫治疗新进展[J].
2024年7月 南京医科大学学报(自然科学版),2024,44(7):1002-1009 ·1009 ·
[59] JIAO Y,LIU M,LUO N,et al. Successful treatment of paclitaxel,and bevacizumab[J]. Respir Med Case Rep,
advanced pulmonary sarcomatoid carcinoma with the PD⁃ 2022,36:101579
1 inhibitor toripalimab:a case report[J]. Oral Oncol, [65]CAI R,LIU Y,SHA H,et al. A case report:a new promis⁃
2021,112:104992 ing treatment for pulmonary sarcomatoid carcinoma⁃Tislel⁃
[60]KIM T H,PARK S H,HWANG I,et al. Robust response izumab and Anlotinib combined with local radiotherapy[J].
of pulmonary pleomorphic carcinoma to pembrolizumab Heliyon,2023,9(11):e21902
and sequential radiotherapy:a case report[J]. Respirol [66] NIAN J,ZHU Y,FU Q,et al. Significant response of
Case Rep,2021,9(12):e875 pulmonary sarcomatoid carcinoma with obstructive atelec⁃
[61]LEE C W,KIM B H,KIM H J. Clinical outcomes of radi⁃ tasis to treatment with the PD⁃1 inhibitor camrelizumab
cal radiotherapy for pulmonary sarcomatoid carcinoma[J]. combined with transbronchial cryoablation:a case report
Radiat Oncol J,2023,41(3):163-171 and literature review[J]. Front Oncol,2022,12:1013047
[62]CHEN Y,GAO M,HUANG Z,et al. SBRT combined with [67]GOTO Y,SU W,LEVY B P,et al. TROPION⁃Lung02:
PD⁃1/PD⁃L1 inhibitors in NSCLC treatment:a focus on Datopotamab deruxtecan(Dato⁃DXd)plus pembrolizumab
the mechanisms,advances,and future challenges[J]. J (pembro)with or without platinum chemotherapy(Pt⁃CT)
Hematol Oncol,2020,13(1):105 in advanced non⁃small cell lung cancer(aNSCLC)[J]. J
[63]SOCINSKI M A,JOTTE R M,CAPPUZZO F,et al. Clin Oncol,2023,41(S16):9004
Atezolizumab for first ⁃ line treatment of metastatic non⁃ [68]WU M,HUANG Q,XIE Y,et al. Improvement of the anti⁃
squamous NSCLC[J]. N Engl J Med,2018,378(24): cancer efficacy of PD⁃1/PD⁃L1 blockade via combination
2288-2301 therapy and PD ⁃ L1 regulation[J]. J Hematol Oncol,
[64]SAWATARI K,IZUMI M,SONE R,et al. A case of 2022,15(1):24
PD⁃L1 negative advanced pulmonary sarcomatoid carcino⁃ [收稿日期] 2024-01-10
ma effectively treated with atezolizumab,carboplatin, (本文编辑:戴王娟)
我刊现已启用网上稿件管理系统,作者登陆
http:∥jnmu.njmu.edu.cn/即可在线投稿并查询
稿件审理情况。